公开(公告)号：US20240075011A1

公开(公告)日：2024-03-07

申请号：US18500142

申请日：2023-11-02

申请人： MITSUBISHI TANABE PHARMA CORPORATION

发明人： Charlotte MERRILL ,  Wendy AGNESE ,  Nazem ATASSI ,  Tara GRABOWSKY ,  Takeshi SAKATA

IPC分类号： A61K31/4152 ,  A61P25/28

CPC分类号： A61K31/4152 ,  A61P25/28

摘要： A method for treating amyotrophic lateral sclerosis includes administering an effective amount of 3-methyl-1-phenyl-2-pyrazolin-5-one or a physiologically acceptable salt thereof to a patient who is in need thereof and meets two or more features selected from a group of identified features.

公开(公告)号：US20210145798A1

公开(公告)日：2021-05-20

申请号：US16753669

申请日：2018-10-04

申请人： MITSUBISHI TANABE PHARMA CORPORATION

发明人： Charlotte MERRILL ,  Wendy AGNESE ,  Nazem ATASSI ,  Tara GRABOWSKY ,  Takeshi SAKATA

IPC分类号： A61K31/4152 ,  A61P25/28

摘要： A method for treating amyotrophic lateral sclerosis includes administering an effective amount of 3-methyl-1-phenyl-2-pyrazolin-5-one or a physiologically acceptable salt thereof to a patient who is in need thereof and meets two or more features selected from a group of identified features.